Maryland Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Maryland Capital Management's CDNA Position: Q1 2022 in Review
Maryland Capital Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 5,094 shares — an estimated $232K sold.
Maryland Capital Management first reported a position in CDNA in Q1 2021 and held it in 4 quarters. The position peaked at $407K in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Maryland Capital Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Maryland Capital Management sold 5,094 CareDx shares in Q1 2022, an estimated $232K.
- Maryland Capital Management first reported a position in CareDx in Q1 2021 and held it in 4 quarters.
- Maryland Capital Management's CareDx position peaked at $407K in Q2 2021.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Maryland Capital Management's 13F filing for Q1 2022, filed 12 May 2022.